This brief explores the coming next generation Internet — a web that is secure, decentralized, sensually immersive and has other advanced features. Below are key trends driving this change.
Our client is currently developing a revolutionary new transdermal drug delivery system that leverages the benefits of ultrasound.
ur client is currently developing a new functionalized silica nanoparticle as a drug delivery vector for nucleic acid payloads.
Our client wishes to acquire injectable products that are currently marketed in Germany.
Our client has developed a digital signal processing algorithm and system that effectively removes undesired audio from television programming.
Our client is identifying pharmaceuticals for in-licensing, supply, and tech transfer with regional exclusivity in Saudi Arabia.
Both ABSOLVE and ABSCENT have been evaluated in the clinic and have been more effective / better tolerated than other obesity therapeutics. Average weight loss is 10 lbs. during the first month’s use
First in class, disease-modifying, once a year infusion for osteoarthritis. Company seeking investment
Our client is a pharmaceutical company seeking US FDA and/or EMA approved Prescription (Rx) Drugs and Medical Foods for the Swiss market in Oncology, Hematology, Infectious Disease, Hepatology, Gastrology, Transplant, Hematology, and
Our client has developed a subcutaneous testosterone implant system that overcomes disadvantages with competing HRT products.